Orthopedic Hyaluronic Acid Market Report 2025 (Global Edition)

Global Orthopedic Hyaluronic Acid Market Report 2024 Market Size Split by Product Type (Single Injection, Multiple Injections, Combination Products), by Treatment Type (Viscosupplementation, Joint Lub...

Orthopedic Hyaluronic Acid Market Report Description

We have various report editions of Orthopedic Hyaluronic Acid Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Orthopedic Hyaluronic Acid Market Insights Video

Competitive Landscape of the Orthopedic Hyaluronic Acid Market

The orthopedic hyaluronic acid market is highly competitive, with numerous pharmaceutical companies offering advanced HA products. Companies are competing on the basis of product innovation, improved efficacy, safety, and ease of use. Many players are focusing on expanding their market presence through partnerships, mergers, and acquisitions, along with regional expansions. Additionally, companies are developing longer-lasting hyaluronic acid formulations to address the growing demand for durable, effective treatments. Strategic collaborations with healthcare providers, hospitals, and clinics are also enhancing market penetration.

In July 2024, Anika Therapeutics announced the Canadian launch of CINGAL for the treatment of knee osteoarthritis pain. The product marketed and sold in Canada by Pendopharm, a division of Pharmascience Inc. Under the current commercialization agreement, Anika will supply CINGAL to Pendopharm for distribution in the Canadian market, where Pendopharm also serves as Anika's exclusive partner for its ORTHOVISC and MONOVISC products. (Source: https://ir.anika.com/Anika-Announces-Full-Market-Release-of-the-Integrity-TM-Implant-System,-a-Regenerative-Hyaluronic-Acid-Based-Scaffold-for-Rotator-Cuff-and-Other-Tendon-Repairs#:~:text=The%20launch%20of%20the%20Integrity,particularly%20around%20rotator%20cuff%20repair.) In August 2021, Seikagaku Corporation announced the launch of HyLink, a single-injection intra-articular viscosupplement for the treatment of knee osteoarthritis in Taiwan, in partnership with TCM Biotech International Corp. HyLink contains a cross-linked hyaluronate hydrogel, developed using Seikagaku’s unique crosslinking technology, which provides long-lasting relief by staying in the knee joint cavity for an extended period after just one 3 mL injection. (Source: https://www.seikagaku.co.jp/en/news/news6643521154003751318/main/0/link/20210802-e.pdf)

Top Companies Market Share in Orthopedic Hyaluronic Acid Industry: (In no particular order of Rank)

• Zimmer Biomet
• Sanofi
• Anika Therapeutics
• Fidia Pharma
• Seikagaku Corporation
• Medytox
• Regenexx
• Chugai Pharmaceutical
• BioPolymer
• Merz Pharmaceuticals
• LG Chem
• Merck
• Bioventus
• OrthogenRx
• Mylan
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Orthopedic Hyaluronic Acid Market

Which Region Dominates the Orthopedic Hyaluronic Acid Market in 2024?

According to Cognitive Market Research, North America currently dominates the orthopedic hyaluronic acid market, and the region is expected to have significant growth during the projected period. This is due to advanced healthcare infrastructure, high adoption rates of minimally invasive procedures, and a significant aging population. The U.S., in particular, has a well-established healthcare system, driving demand for non-surgical treatments such as hyaluronic acid injections.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This is driven by rapid economic development, increasing healthcare access, and growing awareness about joint health. Rising disposable incomes and the aging population in countries like China and Japan are contributing to the increasing demand for OA treatments, boosting market growth.

The current report Scope analyzes Orthopedic Hyaluronic Acid Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Orthopedic Hyaluronic Acid

According to Cognitive Market Research, the global orthopedic hyaluronic acid market size was estimated at USD 9512.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 3804.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• According to Cognitive Market Research, The United States orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 3002.05 million in 2024. The growing aging population and increasing prevalence of osteoarthritis in the U.S. will drive demand for orthopedic hyaluronic acid treatments.
The Canada orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 456.59 million in 2024. Canada's expanding healthcare infrastructure and rising awareness of non-invasive osteoarthritis treatments contribute to the growing adoption of orthopedic hyaluronic acid injections. The Mexico orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 346.24 million in 2024.

Europe Orthopedic Hyaluronic Acid

According to Cognitive Market Research, the global orthopedic hyaluronic acid market size was estimated at USD 9512.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 2853.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• The United Kingdom orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 479.41 million in 2024. The UK’s focus on innovative treatments and increasing demand for non-surgical alternatives to joint pain relief will boost orthopedic hyaluronic acid sales.
The France orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 262.54 million in 2024. The Germany orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 565.02 million in 2024. Germany's advanced medical research and growing number of knee osteoarthritis cases are fueling the adoption of orthopedic hyaluronic acid solutions. The Italy orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 245.41 million in 2024. The Russia orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 442.32 million in 2024. The Spain orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 234.00 million in 2024. The Luxembourg orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 88.46 million in 2024. The Portugal orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 59.93 million in 2024. The Greece orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 34.24 million in 2024. The Rest of Europe orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 442.32 million in 2024.

Asia Pacific Orthopedic Hyaluronic Acid

According to Cognitive Market Research, the global orthopedic hyaluronic acid market size was estimated at USD 9512.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 2187.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.

• According to Cognitive Market Research, China orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 984.51 million in 2024. China’s rapidly aging population, urbanization, and increasing healthcare access will result in higher demand for non-invasive osteoarthritis treatments, including hyaluronic acid injections.
The Japan orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 301.92 million in 2024. The India orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 262.54 million in 2024. India’s expanding middle class and rising incidence of joint-related diseases will drive increased adoption of orthopedic hyaluronic acid treatments for osteoarthritis. The South Korea orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 218.78 million in 2024. The Australia orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 113.77 million in 2024. The South East Asia orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 150.96 million in 2024. The Rest of Asia Pacific orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 155.33 million in 2024.

South America Orthopedic Hyaluronic Acid

According to Cognitive Market Research, the global orthopedic hyaluronic acid market size was estimated at USD 9512.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 475.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 203.56 million in 2024. Brazil's growing healthcare spending, combined with a high rate of osteoarthritis cases, is pushing demand for non-invasive orthopedic hyaluronic acid therapies.
The Argentina orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 79.90 million in 2024. Argentina’s increasing awareness of joint health and affordability of non-surgical treatments is boosting the demand for orthopedic hyaluronic acid in the region. The Colombia orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 42.33 million in 2024. The Peru orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 39.00 million in 2024. The Chile orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 34.24 million in 2024. The Rest of Latin America orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 76.57 million in 2024.

Middle East and Africa Orthopedic Hyaluronic Acid

According to Cognitive Market Research, the global orthopedic hyaluronic acid market size was estimated at USD 9512.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 190.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031..

• The GCC Countries orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 81.42 million in 2024. The GCC's focus on improving healthcare services and rising awareness of osteoarthritis treatments is driving demand for orthopedic hyaluronic acid injections.
The Egypt orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 19.98 million in 2024. The South Africa orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 30.06 million in 2024. In South Africa, a growing awareness of osteoarthritis and the preference for minimally invasive procedures are contributing to the rise in orthopedic hyaluronic acid sales. The Turkey orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 16.36 million in 2024. The Nigeria orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 19.98 million in 2024. The Rest of MEA orthopedic hyaluronic acid market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 22.45 million in 2024.

Orthopedic Hyaluronic Acid Market Analysis

Orthopedic Hyaluronic Acid Market Product Type Segment Analysis

According to Cognitive Market Research, multiple injections are likely to dominate the orthopedic hyaluronic acid market over the forecast period due to their ability to provide longer-lasting relief for patients with joint pain, particularly in osteoarthritis. Patients often require a series of injections to manage symptoms, making this the preferred option.

The combination products is the fastest-growing segment in the orthopedic hyaluronic acid market as they offer enhanced efficacy, targeting both pain and inflammation simultaneously, making them an attractive choice for comprehensive joint therapy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Orthopedic Hyaluronic Acid Industry. Request a Free Sample PDF!

Orthopedic Hyaluronic Acid Market Treatment Type Segment Analysis

According to Cognitive Market Research, the viscosupplementation segment holds the largest share of the market due to its well-established effectiveness in reducing pain and improving mobility in joint conditions like osteoarthritis. It is widely preferred due to its ability to directly restore the synovial fluid, improving lubrication.

In the orthopedic hyaluronic acid market, the joint lubrication has been expanding at a rapid pace as a preventative measure for younger patients or athletes. With growing awareness of joint health, the demand for preventive joint lubrication is increasing.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Orthopedic Hyaluronic Acid Route of Administration Segment Analysis

Orthopedic Hyaluronic Acid Market Route of Administration Segment Analysis

According to Cognitive Market Research, the intra-articular injection segment holds the largest share of the market due to their direct and localized delivery to the joint, leading to quicker relief from pain and inflammation. This method is most commonly used for osteoarthritis patients and has a high success rate.

In the orthopedic hyaluronic acid market, the intra-synovial injection has been expanding at a rapid pace due to their targeted delivery within the synovial cavity, enhancing the distribution of hyaluronic acid for improved efficacy. This method is gaining traction as it provides more precise relief, leading to better patient outcomes.

• Intra-Articular Injection
• Intra-Muscular Injection
• Intra-Synovial Injection

Orthopedic Hyaluronic Acid Application Segment Analysis

Orthopedic Hyaluronic Acid Market Application Segment Analysis

According to Cognitive Market Research, the osteoarthritis segment holds the largest share of the market due to its high prevalence globally, particularly among aging populations. The chronic nature of this disease and the demand for long-term solutions like hyaluronic acid injections drive the majority of sales in this segment.

In the orthopedic hyaluronic acid market, the sports injuries has been expanding at a rapid pace driven by an increasing number of active individuals and athletes seeking non-invasive treatment options to recover from joint injuries. This demand is being fueled by sports-focused healthcare centers and improved awareness of joint preservation techniques.

• Osteoarthritis
• Rheumatoid Arthritis
• Sports Injuries

Orthopedic Hyaluronic Acid End User Segment Analysis

Orthopedic Hyaluronic Acid Market End User Segment Analysis

According to Cognitive Market Research, the hospitals segment holds the largest share of the market due to their access to advanced treatment options and ability to manage complex joint-related conditions. Patients prefer hospitals for surgical and non-surgical interventions, making it the largest user segment.

In the orthopedic hyaluronic acid market, the orthopedic clinics has been expanding at a rapid pace as they specialize in joint care and are increasingly equipped with advanced non-invasive treatment options like hyaluronic acid injections. The convenience of specialized care and personalized treatment is attracting more patients to these centers.

• Hospitals
• Orthopedic Clinics
• Physiotherapy Centers
• Ambulatory Surgical Centers

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion